Key result
Gallic acid at /kg improved cardiac function, increased antioxidant defense, and reduced cell damage in rats with isoproterenol-induced hypertrophic hearts.
Why the study?
Gallic acid has interesting cardiovascular effects, but its protective effects against isoproterenol-induced cardiac damage during ischemia/reperfusion needed investigation.
Does gallic acid protect against isoproterenol-induced cardiotoxicity and ischemia/reperfusion injury in rats?
RCT
Randomized
Does gallic acid protect against isoproterenol-induced cardiotoxicity and ischemia/reperfusion injury in rats?
Answers are grounded in this paper and cite their sources.
Gallic acid at 50 mg/kg demonstrates cardioprotective effects against isoproterenol-induced hypertrophy and ischemia/reperfusion injury in a rat model.
Background Gallic acid (GA) is a polyphenolic agent with interesting pharmacological impacts on the cardiovascular system. Objective The present study purposed to study the protective effects of GA at 25 and 50 mg/kg against isoproterenol (ISO)-induced cardiac damage in ischemia/reperfusion (I/R) in rats. Methods Male Wistar rats were randomly assigned into six groups: Control, Control treated with GA at 25 mg/kg (GA25), Control treated with GA at 50 mg/kg (GA50), Hypertrophic rats induced by ISO (ISO), Hypertrophic rats treated with GA at 25 mg/kg (ISO+GA25), and Hypertrophic rats treated with GA at 50 mg/kg (ISO+GA50). Heart isolation was performed to induce a cardiac I/R injury model. Cardiac hemodynamic parameters were recorded. Serum Lactate Dehydrogenase (LDH) and Creatine Kinase-MB (CK-MB) and cardiac Superoxide dismutases (SOD) levels were evaluated. The gene expression of Sarcoplasmic reticulum Ca 2+ -ATPase (SERCA2a) was assessed. Results We found that GA at 50 mg/kg was significantly increased cardiac function at post I/R period in ISO-induced hypertrophic hearts. Moreover, it suppressed cardiac hypertrophy, the serum LDH and CK-MB levels in ISO injected rats. Administration of GA at 50 mg/kg was significantly increased SOD level and SERCA2a gene expression in the hypertrophic hearts. Conclusion GA at 50 mg/kg could improve cardiac performance possibly by increasing antioxidant defense enzymes, reducing cell damage, and enhancing SERCA2a gene expression in hypertrophic heart induced by ISO in I/R injury conditions.
No takes yet. Share an insight, caveat, or question.
Shackebaei et al. (2022) conducted an RCT in Isoproterenol-induced cardiac damage in ischemia/reperfusion. Gallic acid vs. Control (no treatment or isoproterenol alone) was evaluated on Cardiac function, cardiac hypertrophy, serum LDH and CK-MB levels, SOD level, and SERCA2a gene expression. Gallic acid at /kg improved cardiac function, increased antioxidant defense, and reduced cell damage in rats with isoproterenol-induced hypertrophic hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: